NEXTERONE Drug Patent Profile
✉ Email this page to a colleague
When do Nexterone patents expire, and when can generic versions of Nexterone launch?
Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-nine patent family members in thirteen countries.
The generic ingredient in NEXTERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nexterone
A generic version of NEXTERONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
Summary for NEXTERONE
International Patents: | 29 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 3 |
Patent Applications: | 793 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NEXTERONE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NEXTERONE |
What excipients (inactive ingredients) are in NEXTERONE? | NEXTERONE excipients list |
DailyMed Link: | NEXTERONE at DailyMed |
US Patents and Regulatory Information for NEXTERONE
NEXTERONE is protected by one US patents.
Patents protecting NEXTERONE
Sulfoalkyl ether cyclodextrin compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-002 | Nov 16, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-003 | Nov 16, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NEXTERONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-002 | Nov 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NEXTERONE
See the table below for patents covering NEXTERONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Moldova, Republic of | 1813 | Derivati purificati de ciclodextrina ai eterilor sulfoalchilici sau amestecurile lor, complex clatrat al derivatilor de ciclodextrina cu continut de medicament si compozitie farmaceutica (Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition) | ⤷ Try a Trial |
Australia | 2003234285 | FORMULATIONS CONTAINING AMIODARONE AND SULFOALKYL ETHER CYCLODEXTRIN | ⤷ Try a Trial |
Spain | 2176206 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |